Omada Health, Inc. $OMDA Shares Acquired by BNP Paribas Financial Markets

BNP Paribas Financial Markets raised its holdings in Omada Health, Inc. (NASDAQ:OMDA) by 3,209.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 416,603 shares of the company’s stock after buying an additional 404,016 shares during the period. BNP Paribas Financial Markets’ holdings in Omada Health were worth $6,574,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Perceptive Advisors LLC purchased a new stake in shares of Omada Health during the 2nd quarter worth $44,402,000. Divisadero Street Capital Management LP purchased a new stake in shares of Omada Health during the 3rd quarter worth $30,510,000. Jefferies Financial Group Inc. purchased a new stake in shares of Omada Health during the 4th quarter worth $16,948,000. BIT Capital GmbH purchased a new stake in shares of Omada Health during the 3rd quarter worth $13,639,000. Finally, Madryn Asset Management LP purchased a new stake in shares of Omada Health during the 4th quarter worth $9,212,000.

Insider Activity at Omada Health

In other news, President Wei-Li Shao sold 2,829 shares of the business’s stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $12.71, for a total value of $35,956.59. Following the completion of the sale, the president directly owned 328,850 shares in the company, valued at approximately $4,179,683.50. The trade was a 0.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Steven L. Cook sold 1,884 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $13.94, for a total value of $26,262.96. Following the sale, the chief financial officer owned 200,512 shares in the company, valued at approximately $2,795,137.28. This represents a 0.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 6.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on OMDA shares. Needham & Company LLC reissued a “buy” rating and issued a $28.00 price target on shares of Omada Health in a research report on Friday, May 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Omada Health in a research note on Thursday, June 4th. BMO Capital Markets dropped their price objective on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, March 6th. JPMorgan Chase & Co. dropped their price objective on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research note on Thursday, March 12th. Finally, Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a research note on Friday, May 8th. Ten research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $22.91.

Omada Health Trading Up 2.5%

Shares of OMDA stock opened at $18.32 on Wednesday. The company’s fifty day simple moving average is $15.06 and its 200-day simple moving average is $14.83. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92. The company has a market cap of $1.09 billion and a PE ratio of -67.85.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The company had revenue of $78.05 million during the quarter. Equities research analysts expect that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.